tiprankstipranks
Trending News
More News >
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market

Virax Biolabs Group Ltd. Class A (VRAX) Similar Stocks

Compare
108 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Virax Biolabs Group Ltd. Class A
$0.84
-23.64%
0 Buy
0 Hold
0 Sell
Moderate Buy
Biodexa Pharmaceuticals
$0.88
$581.61K
-96.04%
0 Buy
0 Hold
0 Sell
Moderate Buy
Salarius Pharmaceuticals
$0.88
$1.87M
-62.89%
Quoin Pharmaceuticals
$9.22
$5.43M
-54.71%
0 Buy
0 Hold
0 Sell
Moderate Buy
GRI Bio
$1.37
$3.22M
-94.96%
2 Buy
0 Hold
0 Sell
Moderate Buy
Protagenic Therapeutics
$3.54
$3.07M
-66.86%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
VRAX
Virax Biolabs Group Ltd. Class A
0.84
-0.26
-23.64%
BDRX
Biodexa Pharmaceuticals
0.88
-21.36
-96.04%
SLRX
Salarius Pharmaceuticals
0.90
-1.52
-62.81%
QNRX
Quoin Pharmaceuticals
9.19
-11.10
-54.71%
GRI
GRI Bio
1.37
-25.83
-94.96%
PTIX
Protagenic Therapeutics
3.48
-7.02
-66.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis